Get startedLog in
    Picture of Maravai Lifesciences Holdings logo

    MRVI — Maravai Lifesciences Holdings Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Maravai Lifesciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line78.8469491-138-260
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items17.1-4.59.97-637223
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital35.9-177-45.197.8-12.6
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities1523695361267.46
    Capital Expenditures-25.4-14.8-17.1-65.6-31.2
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items31.5121-251-56.86.84
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Other Investing Cash Flow
    Cash from Investing Activities6.07106-268-122-24.3
    Financing Cash Flow Items-445-155-184-55.30.443
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities53.2-159-187-61.1-236
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash21131580.9-57.2-253